The global market for Travelers Vaccines was estimated to be worth US$ 3363.3 million in 2023 and is forecast to a readjusted size of US$ 6111.4 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030

Travelers Vaccines - Market

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Travelers Vaccines by region & country, by Type, and by End Users.

The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.

Market Segmentation

Scope of Travelers Vaccines - Market Report

Report Metric	Details
Report Name	Travelers Vaccines - Market
Forecasted market size in 2030	US$ 6111.4 million
CAGR	8.8%
Forecasted years	2024 - 2030
Segment by Type:	Meningococcal Vaccine Japanese Encephalitis Vaccine Yellow Fever Vaccine Hepatitis Vaccine Cholera Vaccine Other
Segment by End Users	Tourists Students Workers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Travelers Vaccines in country level. It provides sigmate data by Type, and by End Users for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Travelers Vaccines - Market size in 2030?

Ans: The Travelers Vaccines - Market size in 2030 will be US$ 6111.4 million.

Who are the main players in the Travelers Vaccines - Market report?

Ans: The main players in the Travelers Vaccines - Market are GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai

What are the Type segmentation covered in the Travelers Vaccines - Market report?

Ans: The Types covered in the Travelers Vaccines - Market report are Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other

What are the End User segmentation covered in the Travelers Vaccines - Market report?

Ans: The End users covered in the Travelers Vaccines - Market report are Tourists, Students, Workers, Others

1 Market Overview

1.1 Travelers Vaccines Product Introduction

1.2 Global Travelers Vaccines Market Size Forecast

1.2.1 Global Travelers Vaccines Sales Value (2019-2030)

1.2.2 Global Travelers Vaccines Sales Volume (2019-2030)

1.2.3 Global Travelers Vaccines Sales Price (2019-2030)

1.3 Travelers Vaccines Market Trends & Drivers

1.3.1 Travelers Vaccines Industry Trends

1.3.2 Travelers Vaccines Market Drivers & Opportunity

1.3.3 Travelers Vaccines Market Challenges

1.3.4 Travelers Vaccines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Travelers Vaccines Players Revenue Ranking (2023)

2.2 Global Travelers Vaccines Revenue by Company (2019-2024)

2.3 Global Travelers Vaccines Players Sales Volume Ranking (2023)

2.4 Global Travelers Vaccines Sales Volume by Company Players (2019-2024)

2.5 Global Travelers Vaccines Average Price by Company (2019-2024)

2.6 Key Manufacturers Travelers Vaccines Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Travelers Vaccines Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Travelers Vaccines

2.9 Travelers Vaccines Market Competitive Analysis

2.9.1 Travelers Vaccines Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Travelers Vaccines Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Meningococcal Vaccine

3.1.2 Japanese Encephalitis Vaccine

3.1.3 Yellow Fever Vaccine

3.1.4 Hepatitis Vaccine

3.1.5 Cholera Vaccine

3.1.6 Other

3.2 Global Travelers Vaccines Sales Value by Type

3.2.1 Global Travelers Vaccines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Travelers Vaccines Sales Value, by Type (2019-2030)

3.2.3 Global Travelers Vaccines Sales Value, by Type (%) (2019-2030)

3.3 Global Travelers Vaccines Sales Volume by Type

3.3.1 Global Travelers Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Travelers Vaccines Sales Volume, by Type (2019-2030)

3.3.3 Global Travelers Vaccines Sales Volume, by Type (%) (2019-2030)

3.4 Global Travelers Vaccines Average Price by Type (2019-2030)

4 Segmentation by End Users

4.1 Introduction by End Users

4.1.1 Tourists

4.1.2 Students

4.1.3 Workers

4.1.4 Others

4.2 Global Travelers Vaccines Sales Value by End Users

4.2.1 Global Travelers Vaccines Sales Value by End Users (2019 VS 2023 VS 2030)

4.2.2 Global Travelers Vaccines Sales Value, by End Users (2019-2030)

4.2.3 Global Travelers Vaccines Sales Value, by End Users (%) (2019-2030)

4.3 Global Travelers Vaccines Sales Volume by End Users

4.3.1 Global Travelers Vaccines Sales Volume by End Users (2019 VS 2023 VS 2030)

4.3.2 Global Travelers Vaccines Sales Volume, by End Users (2019-2030)

4.3.3 Global Travelers Vaccines Sales Volume, by End Users (%) (2019-2030)

4.4 Global Travelers Vaccines Average Price by End Users (2019-2030)

5 Segmentation by Region

5.1 Global Travelers Vaccines Sales Value by Region

5.1.1 Global Travelers Vaccines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Travelers Vaccines Sales Value by Region (2019-2024)

5.1.3 Global Travelers Vaccines Sales Value by Region (2025-2030)

5.1.4 Global Travelers Vaccines Sales Value by Region (%), (2019-2030)

5.2 Global Travelers Vaccines Sales Volume by Region

5.2.1 Global Travelers Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Travelers Vaccines Sales Volume by Region (2019-2024)

5.2.3 Global Travelers Vaccines Sales Volume by Region (2025-2030)

5.2.4 Global Travelers Vaccines Sales Volume by Region (%), (2019-2030)

5.3 Global Travelers Vaccines Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Travelers Vaccines Sales Value, 2019-2030

5.4.2 North America Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Travelers Vaccines Sales Value, 2019-2030

5.5.2 Europe Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Travelers Vaccines Sales Value, 2019-2030

5.6.2 Asia Pacific Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Travelers Vaccines Sales Value, 2019-2030

5.7.2 South America Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Travelers Vaccines Sales Value, 2019-2030

5.8.2 Middle East & Africa Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Travelers Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Travelers Vaccines Sales Value

6.2.1 Key Countries/Regions Travelers Vaccines Sales Value, 2019-2030

6.2.2 Key Countries/Regions Travelers Vaccines Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Travelers Vaccines Sales Value, 2019-2030

6.3.2 United States Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Travelers Vaccines Sales Value by End Users, 2023 VS 2030

6.4 Europe

6.4.1 Europe Travelers Vaccines Sales Value, 2019-2030

6.4.2 Europe Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Travelers Vaccines Sales Value by End Users, 2023 VS 2030

6.5 China

6.5.1 China Travelers Vaccines Sales Value, 2019-2030

6.5.2 China Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Travelers Vaccines Sales Value by End Users, 2023 VS 2030

6.6 Japan

6.6.1 Japan Travelers Vaccines Sales Value, 2019-2030

6.6.2 Japan Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Travelers Vaccines Sales Value by End Users, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Travelers Vaccines Sales Value, 2019-2030

6.7.2 South Korea Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Travelers Vaccines Sales Value by End Users, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Travelers Vaccines Sales Value, 2019-2030

6.8.2 Southeast Asia Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Travelers Vaccines Sales Value by End Users, 2023 VS 2030

6.9 India

6.9.1 India Travelers Vaccines Sales Value, 2019-2030

6.9.2 India Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Travelers Vaccines Sales Value by End Users, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Company Information

7.1.2 GlaxoSmithKline Introduction and Business Overview

7.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GlaxoSmithKline Travelers Vaccines Product Offerings

7.1.5 GlaxoSmithKline Recent Development

7.2 Sanofi Pasteur

7.2.1 Sanofi Pasteur Company Information

7.2.2 Sanofi Pasteur Introduction and Business Overview

7.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi Pasteur Travelers Vaccines Product Offerings

7.2.5 Sanofi Pasteur Recent Development

7.3 Merck

7.3.1 Merck Company Information

7.3.2 Merck Introduction and Business Overview

7.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Merck Travelers Vaccines Product Offerings

7.3.5 Merck Recent Development

7.4 Pfizer

7.4.1 Pfizer Company Information

7.4.2 Pfizer Introduction and Business Overview

7.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Travelers Vaccines Product Offerings

7.4.5 Pfizer Recent Development

7.5 CNBG

7.5.1 CNBG Company Information

7.5.2 CNBG Introduction and Business Overview

7.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.5.4 CNBG Travelers Vaccines Product Offerings

7.5.5 CNBG Recent Development

7.6 Sanofi Pasteur MSD

7.6.1 Sanofi Pasteur MSD Company Information

7.6.2 Sanofi Pasteur MSD Introduction and Business Overview

7.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Offerings

7.6.5 Sanofi Pasteur MSD Recent Development

7.7 Serum Institute of India

7.7.1 Serum Institute of India Company Information

7.7.2 Serum Institute of India Introduction and Business Overview

7.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Serum Institute of India Travelers Vaccines Product Offerings

7.7.5 Serum Institute of India Recent Development

7.8 Biokangtai

7.8.1 Biokangtai Company Information

7.8.2 Biokangtai Introduction and Business Overview

7.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biokangtai Travelers Vaccines Product Offerings

7.8.5 Biokangtai Recent Development

8 Industry Chain Analysis

8.1 Travelers Vaccines Industrial Chain

8.2 Travelers Vaccines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Travelers Vaccines Sales Model

8.5.2 Sales Channel

8.5.3 Travelers Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Serum Institute of India

Biokangtai

List of Tables

Table 1. Travelers Vaccines Market Trends

Table 2. Travelers Vaccines Market Drivers & Opportunity

Table 3. Travelers Vaccines Market Challenges

Table 4. Travelers Vaccines Market Restraints

Table 5. Global Travelers Vaccines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Travelers Vaccines Revenue Market Share by Company (2019-2024)

Table 7. Global Travelers Vaccines Sales Volume by Company (2019-2024) & (K Doses)

Table 8. Global Travelers Vaccines Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Travelers Vaccines Price by Company (2019-2024) & (USD/Dose)

Table 10. Key Manufacturers Travelers Vaccines Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Travelers Vaccines Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Travelers Vaccines

Table 13. Global Travelers Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Travelers Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Travelers Vaccines Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Travelers Vaccines Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Travelers Vaccines Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Travelers Vaccines Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Travelers Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)

Table 22. Global Travelers Vaccines Sales Volume by Type (2019-2024) & (K Doses)

Table 23. Global Travelers Vaccines Sales Volume by Type (2025-2030) & (K Doses)

Table 24. Global Travelers Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Travelers Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Travelers Vaccines Price by Type (2019-2024) & (USD/Dose)

Table 27. Global Travelers Vaccines Price by Type (2025-2030) & (USD/Dose)

Table 28. Global Travelers Vaccines Sales Value by End Users: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Travelers Vaccines Sales Value by End Users (2019-2024) & (US$ Million)

Table 30. Global Travelers Vaccines Sales Value by End Users (2025-2030) & (US$ Million)

Table 31. Global Travelers Vaccines Sales Market Share in Value by End Users (2019-2024) & (%)

Table 32. Global Travelers Vaccines Sales Market Share in Value by End Users (2025-2030) & (%)

Table 33. Global Travelers Vaccines Sales Volume by End Users: 2019 VS 2023 VS 2030 (K Doses)

Table 34. Global Travelers Vaccines Sales Volume by End Users (2019-2024) & (K Doses)

Table 35. Global Travelers Vaccines Sales Volume by End Users (2025-2030) & (K Doses)

Table 36. Global Travelers Vaccines Sales Market Share in Volume by End Users (2019-2024) & (%)

Table 37. Global Travelers Vaccines Sales Market Share in Volume by End Users (2025-2030) & (%)

Table 38. Global Travelers Vaccines Price by End Users (2019-2024) & (USD/Dose)

Table 39. Global Travelers Vaccines Price by End Users (2025-2030) & (USD/Dose)

Table 40. Global Travelers Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Travelers Vaccines Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Travelers Vaccines Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Travelers Vaccines Sales Value by Region (2019-2024) & (%)

Table 44. Global Travelers Vaccines Sales Value by Region (2025-2030) & (%)

Table 45. Global Travelers Vaccines Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030

Table 46. Global Travelers Vaccines Sales Volume by Region (2019-2024) & (K Doses)

Table 47. Global Travelers Vaccines Sales Volume by Region (2025-2030) & (K Doses)

Table 48. Global Travelers Vaccines Sales Volume by Region (2019-2024) & (%)

Table 49. Global Travelers Vaccines Sales Volume by Region (2025-2030) & (%)

Table 50. Global Travelers Vaccines Average Price by Region (2019-2024) & (USD/Dose)

Table 51. Global Travelers Vaccines Average Price by Region (2025-2030) & (USD/Dose)

Table 52. Key Countries/Regions Travelers Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Travelers Vaccines Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Travelers Vaccines Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Travelers Vaccines Sales Volume, (2019-2024) & (K Doses)

Table 56. Key Countries/Regions Travelers Vaccines Sales Volume, (2025-2030) & (K Doses)

Table 57. GlaxoSmithKline Company Information

Table 58. GlaxoSmithKline Introduction and Business Overview

Table 59. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 60. GlaxoSmithKline Travelers Vaccines Product Offerings

Table 61. GlaxoSmithKline Recent Development

Table 62. Sanofi Pasteur Company Information

Table 63. Sanofi Pasteur Introduction and Business Overview

Table 64. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 65. Sanofi Pasteur Travelers Vaccines Product Offerings

Table 66. Sanofi Pasteur Recent Development

Table 67. Merck Company Information

Table 68. Merck Introduction and Business Overview

Table 69. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 70. Merck Travelers Vaccines Product Offerings

Table 71. Merck Recent Development

Table 72. Pfizer Company Information

Table 73. Pfizer Introduction and Business Overview

Table 74. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 75. Pfizer Travelers Vaccines Product Offerings

Table 76. Pfizer Recent Development

Table 77. CNBG Company Information

Table 78. CNBG Introduction and Business Overview

Table 79. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 80. CNBG Travelers Vaccines Product Offerings

Table 81. CNBG Recent Development

Table 82. Sanofi Pasteur MSD Company Information

Table 83. Sanofi Pasteur MSD Introduction and Business Overview

Table 84. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 85. Sanofi Pasteur MSD Travelers Vaccines Product Offerings

Table 86. Sanofi Pasteur MSD Recent Development

Table 87. Serum Institute of India Company Information

Table 88. Serum Institute of India Introduction and Business Overview

Table 89. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 90. Serum Institute of India Travelers Vaccines Product Offerings

Table 91. Serum Institute of India Recent Development

Table 92. Biokangtai Company Information

Table 93. Biokangtai Introduction and Business Overview

Table 94. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 95. Biokangtai Travelers Vaccines Product Offerings

Table 96. Biokangtai Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Travelers Vaccines Downstream Customers

Table 100. Travelers Vaccines Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Travelers Vaccines Product Picture

Figure 2. Global Travelers Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Travelers Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Travelers Vaccines Sales Volume (2019-2030) & (K Doses)

Figure 5. Global Travelers Vaccines Sales Price (2019-2030) & (USD/Dose)

Figure 6. Travelers Vaccines Report Years Considered

Figure 7. Global Travelers Vaccines Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Travelers Vaccines Players Sales Volume Ranking (2023) & (K Doses)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Travelers Vaccines Revenue in 2023

Figure 10. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Meningococcal Vaccine Picture

Figure 12. Japanese Encephalitis Vaccine Picture

Figure 13. Yellow Fever Vaccine Picture

Figure 14. Hepatitis Vaccine Picture

Figure 15. Cholera Vaccine Picture

Figure 16. Other Picture

Figure 17. Global Travelers Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Travelers Vaccines Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Travelers Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)

Figure 20. Global Travelers Vaccines Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Travelers Vaccines Price by Type (2019-2030) & (USD/Dose)

Figure 22. Product Picture of Tourists

Figure 23. Product Picture of Students

Figure 24. Product Picture of Workers

Figure 25. Product Picture of Others

Figure 26. Global Travelers Vaccines Sales Value by End Users (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Travelers Vaccines Sales Value Market Share by End Users, 2023 & 2030

Figure 28. Global Travelers Vaccines Sales Volume by End Users (2019 VS 2023 VS 2030) & (K Doses)

Figure 29. Global Travelers Vaccines Sales Volume Market Share by End Users, 2023 & 2030

Figure 30. Global Travelers Vaccines Price by End Users (2019-2030) & (USD/Dose)

Figure 31. North America Travelers Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Travelers Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Travelers Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Travelers Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Travelers Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Travelers Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Travelers Vaccines Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Travelers Vaccines Sales Volume (%), (2019-2030)

Figure 43. United States Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 46. Europe Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 49. China Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 51. China Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 52. Japan Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 55. South Korea Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 58. Southeast Asia Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 61. India Travelers Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Travelers Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 63. India Travelers Vaccines Sales Value by End Users (%), 2023 VS 2030

Figure 64. Travelers Vaccines Industrial Chain

Figure 65. Travelers Vaccines Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions